JPRN-UMIN000009308招募中2 期
Phase II study of Carboplatin and alternate-day administrations of TS-1 in patients with advanced squamous cell lung cancer. - Phase II study of Carboplatin and alternate-day administrations of TS-1 in patients with advanced squamous cell lung cancer.
Kyoto Thoracic Oncology Research Group0 个研究点目标入组 35 人开始时间: 2013年1月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Contraindication of TS-1, CBDCA 2)Patients received adjuvant chemotherapy 3.Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 4.Active infection 5.HBs antigen positive 6.Severe complications, such as ileus, heart failure and renal failure 7.Continuous diarrhea 8.Massive pleural effusion and ascites 9.Active concomitant malignancy 10.Patients under treatment with flucytosine, phenytoin or warfarin potassium 11.Patients under treatment with steroids 12.Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
不适用
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.terine cervical cancerJPRN-UMIN000017232Osaka University Hospital80
已完成
2 期
A Phase II Study of daily carboplatin plus irradiation followed by Durvalumab for previously-untreated Stage III NSCLC patients with PS2 and/or high agenon-small cell lung cancerJPRN-jRCTs031190070Kaira Kyoichi95
已完成
不适用
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
已完成
2 期
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30